|
FluimediX is developing the NanoCycler™ device. The NanoCycler™ is a tabletop device designed to accept a disposable polymer cartridge, in which a number of biochemical reactions are performed on a human saliva sample.
The NanoCycler™ will deliver an identification of the presence of – respectively lack of – a number of genetic mutations; the so-called SNPs – Single Nucleotide Polymorphisms.
FluimediX has used CYP2C19*2 SNP as a model marker to demonstrate proof-of-concept, -principle and -functionality of the NanoCycler™.
ttttcccact atcattgatt atttcccgggg aacccataac aaattactta
ttttcccact atcattgatt atttcccgagg aacccataac aaattactta (CYP2C19 *2)
|